Ontogeny of bradykinin B2 receptors in the rat kidney: Implications for segmental nephron maturation. Kinins modulate renal function, yet their role in the developing kidney is largely unknown. To explore the developmental role of the kallikrein-kinin system, we examined the postnatal ontogeny and intrarenal localization of B2 receptors in the rat. Northern blot analysis and RT-PCR documented the expression of B2 receptor mRNA in the kidney and extrarenal tissues of fetal, neonatal and adult animals. The abundance of B2 receptor mRNA is 10-to 30-fold higher in neonatal than adult tissues in the following order: kidney > heart > aorta > lung > brain. Receptor autoradiography revealed a gradual shift in the localization of bradykinin binding sites from the outer cortex in the newborn to the outer medulla in weanling and maturing rats. The almost complete displacement of [1251]tyr°-bradykinin by HOE-140 indicates that the majority of kinin receptors in the developing kidney belong to the B2 type. Immunolocalization studies using antipeptide antibodies directed against various portions of the receptor revealed that B2 receptors are first expressed on the luminal aspect of the upper limb of S-shaped bodies and differentiating cortical collecting ducts. In marked contrast, the metanephnc mesenchyme, pretubular aggregates and glomeruli display weak or no B2 receptor immunoreactivity. Following completion of nephrogenesis, B2 receptor expression shifts to both luminal and basolateral aspects of connecting tubules and collecting ducts. The results demonstrate that bradykinin B2 receptor gene expression is activated in the developing kidney and cardiovascular system. The spatially restricted expression of B2 receptors in the differentiating epithelium of the distal nephron, the site of kinin formation, supports the hypothesis that kinins are paracrine modulators of segmental nephron maturation.
studies have shown that some of these tissues express a local kallikrein-kinin system (KKS) [8, 9] . In the mature kidney, the KKS plays an important role in the regulation of renal blood flow and sodium excretion [10] [11] [12] . In the heart and blood vessels, kinins preserve myocardial function and structure and attenuate neointima formation following vessel injury [13, 14] . In the brain, kinins appear to be involved in the central regulation of blood pressure [15] .
There is increasing awareness that, in addition to its vasoactive actions, bradykinin can stimulate a mitogenic response in quiescent fibroblasts, vascular smooth muscle cells and glomerular mesangial cells [16] [17] [18] [19] . The growth-related effects of kinins are receptor-mediated and are associated with activation of a Gprotein, phosphoinositide hydrolysis and intracellular calcium mobilization [20] . Recent data indicate that tyrosine kinasedependent pathways are also stimulated by B2 receptors [211.
Kinin-stimulated cellular growth is observed in vivo during early development. We and others [22] [23] [24] have reported that renal kallikrein gene transcription and enzymatic activity are developmentally up-regulated during the preweaning period in the rat. In contrast, the expression and activity of kininase II, the major kinin-degrading enzyme, are low in the fetal and neonatal kidney [25, 26] , suggesting intrarenal kinin accumulation during the developing period. Blockade of B2 receptors with HOE-140 during neonatal development suppresses the maturational increase in kidney DNA synthesis [27] . In addition, preliminary data indicate that blockade of B2 receptors during fetal life results in renal hypoplasia and abnormal tubular differentiation [28] .
In spite of the accumulating evidence suggesting a developmen-(a! role for the KKS, little if anything is known regarding the developmental and tissue-specific expression of kinin receptors. Taking advantage of the molecular cloning of the B2 receptor and the recent development of specific antibodies directed to various regions of the B2-receptor, in the present study we examined the ontogeny and distribution of bradykinin B2 receptors during segmental nephron differentiation. Methods RNA preparation and Northern blot analysis Newborn (1, 5, 12 and 20 days of postnatal life) and adult male (150 to 250 g) Sprague-Dawley rats (Charles River Laboratories) were used for the gene expression studies. Each age group consisted of 10 to 14 rat pups obtained from 3 to 5 litters. The following organs were harvested: kidney, heart, aorta, lung, brain and liver. Tissues were snap frozen in liquid nitrogen and subsequently kept at -80°C until use. Tissue total RNA was extracted using the guanidinium isothiocyanate-phenol-chloroform method of Chomczynski and Sacchi [29] . Poly A RNA was isolated by oligo-dT chromatography of total RNA. Poly A RNA (6 jg/ sample) was resolved by electrophoresis on 1% agarose gels containing 2.2 M formaldehyde followed by a transfer to a positively charged nylon membrane (GeneScreen Plus, NEN). The probes consisted of a full-length (1.9 kb) rat B2 receptor cDNA [4] , and a human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA (from American Type Culture). Radiolabeling of the probes with 32P-dCTP was accomplished by the random primer technique, and hybridization and posthybridization washes were performed at 65°C as previously described [30] . Hybridization signals were quantitated by laser densitometry and were factored for those of GAPDH to correct for differences in RNA loading.
Reverse transcription-polymerase chain reaction (RT-PCR) of B2 mRNA RT-PCR of B2 receptor mRNA was performed as recently described [30] MgCl2] and 200 U of MLV reverse transcriptase Superscript II (BRL). RT was performed using Perkin Elmer Gene Amp PCR System 2400 (Cetus Instruments, Norwalk, CT, USA) at 37°C for 50 minutes and the RT enzyme was inactivated by heating at 70°C for 10 minutes. The template mRNA was degraded by incubating the samples with 2 U of E. coli RNase H at 37°C for 20 minutes. cDNA was amplified from one fourth of the RT mixture by PCR using B2 receptor gene-specific primers ( following digestion of 0.5 ag of the product with 3 U of NcoI restriction enzyme at 37°C for one hour and by Southern blotting [30] .
As an internal standard for the efficiency of amplification, one fifth of the RT product was also used to amplify GAPDH mRNA sequences. The upstream primer [5'-AATGCATCCTGACCACcIAACTGC-3'] corresponds to nucleotides 524 to 547, and the downstream primer [5 '-GGCGGCCATGTAGGCCATCTG-GAG-3'] is complementary to nucleotides 1055-1078 of rat GAPDH eDNA [31] . PCR conditions were as follows: 94°C, five minutes; 55°C, one minute; 72°C, seven minutes. The predicted size of the PCR product is 555 bp. ['251 ]-iodine as previously described [32] . After labeling, the iodinated peptide was separated from the unlabeled fraction by high performance liquid chromatography. Rat kidney samples were rapidly frozen in liquid nitrogen, sectioned (15 im thick) in a cryostat at -30°C, mounted on slides precoated with polylysine (Sigma), and stored in plastic boxes at -70°C until use. Before incubation, the sections were warmed to room temperature, freeze dried and washed with 0.05 M Tris-HCI buffer, pH 7.6 containing 0.1% bovine serum albumin, 1 mvt ethylenediamine tetraacetic acid, 1 m ethylene glycol bis-(/3-aminoethyl ether) tetraacetic acid and 20 rM captopril (washing buffer). Incubation with 3 nM [1251]Tyr°-bradykinin in washing buffer supplemented with 1 mM dithiothreitol and 140 rg/ml bacitracin (Sigma) was performed overnight at 4°C. After incubation, the sections were washed with cold washing buffer (3 >< I mm) and distilled water
(1 x 1 mm), dried rapidly with a fan and exposed to Kodak Biomax photographic film for 72 hours at -20°C. Specificity of the binding was assessed by incubating consecutive sections in the presence of 3 jIM of unlabeled Tyr°-bradykinin or the B2 antagonist HOE-140.
Production of anti-peptide antibodies to the bradykinin B2-receptor Eight peptide segments were selected from the corresponding cDNA sequence of the rat B2 receptor [3] by the criteria of hydrophilicity, antigenicity and relative location in the receptor protein. In this way, peptides covering seven of the eight predicted intra-and extracellular domains of the transmcmbrane-spanning receptor were synthesized. The peptides were then covalently coupled to keyhole limpet hemocyanine and used for the generation of eight polyclonal antisera (A5276 to AS283, Table I ) in rabbits following established immunization procedures. When used on tissue sections, the staining pattern produced by the antisera has revealed a receptor distribution that is in essence congruent with the conventional autoradiographic visualization of the B2 receptor [33] . Further, the antibodies strongly recognize their corresponding antigens and crossreact both with the denatured and the native B2 receptor [34] . periodate-lysine-paraformaldehyde buffered at pH 7.4 for 24 hours at room temperature [35] . After fixation the samples were dehydrated in ethanol and embedded in Histosee (Merck; Darmstadt, Germany) as previously described [33] . Immunostaining was performed according to the peroxidase/anti-peroxidase (PAP) method of Sternberger et al [361 with modifications described earlier [37, 381 . Briefly, dewaxed tissue sections were rehydrated, washed with 0.05 M Tris-0.15 M NaC1, pH 7.8 and treated with absolute methanol/10% (vol/vol) H202 for 15 minutes each to block residual pscudopcroxidasc activity. Anti-peptide antibodies (AS276 to AS283, Table 1 ) were used as a pool combination, prepared by mixing the eight different antisera (1:500 to 1:1000), or individually (1:100 to 1:200). Antisera were diluted in washing buffer containing 1% immunoglohulin-free bovine serum albumin (Sigma). Incubation with the B2 receptor antisera was performed overnight at 22°C in a water bath that was used as a moist chamber, The second antibody (swine anti-rabbit IgG, Dako; Carpinteria, CA, USA) at a dilution of 1:80, and the PAP complex (Dako) at 1:100 were applied for 30 minutes each. The peroxidase activity was visualized by incubating the sections in a 0.1% (wt/vol) of 3,3'-diaminohenzidine (Sigma) and 0.03% (vol/vol) of H202 solution for 15 minutes in the dark.
Controls for the immunostaining procedure were prepared by omission of the first antibody and its replacement by non-immune rabbit serum at the same dilutions. Alternatively, the sections were incubated with the pool mixture of anti-peptide antisera (AS276 to AS283) in the presence of a large molar excess of the same peptides (100 to 200 j.tg/ml) used for immunization. After overnight competition the sections were washed and immunostained as already described.
In viva binding of the bradykinin B2 receptor antagonist Newborn rats (day 1) were injected daily until day 8 with the bradykinin B2 receptor antagonist HOE-140 (500 pg/kg body wt dissolved in sterile 0.9% NaC1, s.c., N = 16). A control group was performed by injecting the same number of rats with the vehicle alone, On day 8, after 15 minutes of the last injection, the rats were sacrified under ether anesthesia and the kidneys gently removed and fixed with periodate-lysine-paraformaldehyde as described above. Next, the tissue was dehydrated and embedded in Flistosec or directly frozen and sectioned in a cryostat. SectiorLs from both frozen (15 tm thick) and embedded material (5 to 7 jxm thick) were incubated with various polyclonal and monoclonal antibodies raised against the B2 antagonist HOE-140: MHOI, culture supernatant (1:100); MHO2, ascitic fluid (1:5,000); rabbit antiserum AS255 (1:1000). The anti-antagonist antibodies have been well characterized and used to visualize the B2 receptor ofl tissue sections and on Western blots [33, 34, [39] [40] [41] [42] [43] . Controls were carried out during the immunohistochemical procedure by omission and replacement of the anti-antagonist antibodies by non-immune rabbit serum or mouse lgG. 
Results

Ontogeny of bradykinin B2 receptor gene expression
The results of the RNA hybridization analysis are shown in Fig.  1 . Northern blots of total and polyadenylated RNA isolated from neonatal, weanling and adult rat tissues were probed with radiolabeled B2 receptor or GA.PDH cDNAs. B2 receptor message is detected in the kidney, heart, aorta, lung and brain ( Fig. 1) but not the liver (not shown). The size of the B2 receptor mRNA (4.0 kb) is identical in developing and mature animals indicating the absence of any developmentally regulated posttranscriptional modification such as differential splicing or polyadenylation. Figure 1 also shows that the relative abundance of B2 receptor mRNA levels is considerably higher in the tissues of neonatal than adult rats (kidney, 30-fold; aorta and heart, 15-fold; lung, 10-fold). The exception to this is the brain, where B2 mRNA levels actually increase fivefold with maturation. In addition, in the newborn B2 receptor mRNA levels are most abundant in the kidney and heart followed by the aorta, lungs and brain (Fig. 1) . The relatively greater expression of B2 receptor mRNA in the kidney and cardiovascular system is particularly apparent during the preweaning period (birth to day 21). In contrast, GAPDH gene expression remained relatively stable during postnatal maturation.
The temporal expression of B2 receptor mRNA was also studied using a highly sensitive RT-PCR assay. As shown in Collectively, these data demonstrate that the bradykinin B2 receptor gene is subject to considerable developmental and tissue-specific regulation.
Autoradiographic detection of the bradykinin B2 receptor Autoradiography revealed the existence of bradykinin-binding sites from the first day after birth with a gradual increase in the intensity of the radiolabeling during the pre-wearting period, in addition, a differential pattern of distribution was observed during postnatal maturation (Fig. 3, A-L ). In the kidney of i-to .a'.
----.c. 12-day-old rats, the B2 binding sites were mainly located in the renal cortex (Fig. 3, A-H) , whereas from day 30 to adult life, the radioactive labeling was concentrated in the outer stripe of the outer medulla (Fig. 3, K-L) . At day 22, however, bradykinin binding sites were found in both the cortex and in outer stripe of the outer medulla (Fig. 3, 1, J) .
Competition experiments on consecutive kidney sections showed that virtually all [1251jTyr°-bradykinin binding was displaced when the sections were coincubated with the radioligand and a molar excess of unlabeled bradykinin (not shown) or the B2 antagonist HOE-140 (Fig. 3, right panel) Between day 1 and day 12, immunolabeled B2 receptors (immunoreactive protein) were present in collecting ducts and in distal nephron segments that in some cases could be clearly recognized as connecting tubules (Fig. 4, A-D) . Faint or no immunoreactivity was observed in mature glomeruli and in proximal convoluted tubules. From day 22, in addition to the presence of immunoreactive B2 receptors in distal nephron segments and in cortical collecting ducts, B2 receptors were concentrated in the outer stripe of the outer medulla including the medullary rays (Fig. 4, E-H) . At this site, the immunoreactivity was mainly localized in collecting ducts and to a less extent in the straight portion of proximal tubules (Fig. 4, E-H) . Further, B2 receptor immunoreactivity was observed in the medullary collecting ducts in the inner stripe of the outer medulla and in the inner medulla (Fig. 4, F, H) . High power views of kidney sections obtained from days 1 and 3 revealed the presence of immunoreactive B2 receptors in the upper limb of S-shaped nephrons and cortical collecting ducts of the developing cortex. The immunolabeling of these structures was exclusively associated to their luminal membranes (Fig. 5, A,  C) . In contrast, well differentiated distal nephron segments and cortical collecting ducts displayed immunoreactive B2 receptors on both luminal and basolateral cell membranes. This stagedependent pattern of immunostaining was observed throughout postnatal development (Fig. 5, B, D-F) . In marked contrast to the distinct immunolocalization of B2 receptors in the differentiating tubular segments, no significant immunostaining could be identified in the subcapsular mesenchyme or pretubular aggregates.
Control slides showed no specific immunostaining when the anti-peptide antiserum mixture was replaced by non-immune serum (Fig. 6) or omitted (not shown) . Furthermore, preabsorption of the antisera mixture with an excess (100 to 200 ig/ml) of the same peptides used for immunization completely quenched the specific immunostaining (not shown).
In vivo labeling of bradykinin B2 receptors
The daily injection of the B2 antagonist, HOE-140, to newborn rats resulted in the in vivo labeling of renal structures in a similar distribution to that demonstrated by autoradiography with [125I] Tyr°-bradykinin or by immunocytochemistry with anti-peptide antibodies. On day 8, the binding of HOE-140, revealed by immunoeytochemistry with monoclonal and polyclonal antibodies raised against HOE-140, was strong and uniform in the cortex and less intense in the outer and inner medulla (Fig. 7A) . No immunoreactivity to HOE-140 was observed in the kidneys of rats injected with the vehicle alone (Fig. 7B) or when the antibodies directed to HOE-140 were replaced by non-immune serum (not shown).
The HOE-140 immunoreactive nephron segments observed in the cortex included cortical collecting ducts, connecting tubules and some proximal tubules whereas no labeling was found in the glomeruli. I-IOE-140 immunoreactivity was associated to both the luminal and the basolateral cell membranes of distal nephron segments such as collecting ducts and connecting tubules, including those tubules located in the outermost cortex (Fig. 7, C-F) . In proximal tubules, HOE-140 immunoreactivity was mainly associated with the luminal side and particularly in reabsorption droplets (Fig. 7G) . Staining was also observed in isolated collecting duct cells of the outer and inner medulla. In these cells, the immunoreactivity usually occupied the whole cytoplasm of collecting duct cells (not shown).
Discussion
The present study demonstrates that the bradykinin B2 receptor gene is expressed in a developmentally regulated and tissue/cellspecific manner. B2 receptor gene expression in the kidney is highly activated in the newborn and throughout the first month of postnatal life. Enhanced B2 receptor expression is also observed in the developing heart and aorta, and the temporal postnatal changes closely parallel those observed in the kidney. In contrast, B2 receptor mRNA expression in the brain increases postnatally and is not detectabie in the maturing liver. These differential tissue-specific changes in gene expression suggest that B2 receptor gene transcription is controlled by tissue-specific and developmentally regulated trans-acting factors. Analysis of the 5'-upstream region of the rat B2 receptor gene reveals the presence of putative cAMP-and interleukin-6 responsive elements [I.
Whether these regulatory regions are involved in the developmental activation of the B2 receptor gene is an interesting topic for future investigation.
A contributing factor to the developmental regulation of the bradykinin B2 receptor gene may be the age-related changes in tissue kallikrein and local kinin levels. We have recently shown that kallikrein-like activity in the kidney, heart and aorta is low in the near-term fetus and increases dramatically (up to 20-fold) during the preweaning period (birth to day 21) in the rat [22] .
These changes in kallikrein activity are accompanied by parallel changes in tissue immunoreactive kallikrein contents, mRNA accumulation, and gene transcription rate [22] [23] [24] . The reciprocal developmental expression of tissue kallikrein and B2 receptor genes suggests that the maturational increase in tissue kallikrein/ kinin activity may exert a negative feedback effect on B2 receptor expression.
The functional relevance of B2 receptor activation in the developing animal is not entirely clear. Nephron growth is accomplished by both cellular hyperplasia and hypertrophy and both processes are highly active during the latter stages of renal organogenesis. On the other hand, postnatal cardiac growth is mainly accomplished by cellular hypertrophy. Pharmacologic blockade of B2 receptors with HOE-140 during the newborn period in the rat results in a tissue-selective reduction in renal and cardiac growth [27] , consistent with the up-regulated expression of B2 receptors in these tissues. When the kinin antagonist is administered during fetal life, renal tubular ectasia and interstitial fibrosis become also evident [28] . Thus, bradykinin B2 receptors may be important for neonatal renal and cardiac growth.
In the adult animal, bradykinin increases renal blood flow and promotes natriuresis, whereas B7 receptor blockade decreases medullary blood flow and urinary sodium excretion [10] [11] [12] . In the developing animal, intrarenal kinins are important in counteracting angiotensin-mediated vasoconstriction [40] . The localization of B2 receptors in the collecting ducts and the ability of bradykinin to modulate sodium and water excretion [10] [11] [12] are also in keeping with a role for B2 receptors in blood volume homeostasis in the developing animal.
The results of the immunocytochemical localization of B2 receptors with anti-peptide antibodies provide important clues to the function of kinins during segmental nephron maturation. The lack of B2 receptor expression in the undifferentiated mesenchyme or pretubular aggregates indicates that kinins are unlikely to be involved in mesenchymal-epithelial conversion nor to modulate the number of induced nephrons. Rather, the distinct and restricted localization of B2 receptors in the differentiating epithelium of stage II to IV nephrons strongly suggests that activation of B2 receptors may be more important for tubular growth! differentiation and acquisition of function. This hypothesis is strengthened by the fact that all the components of the KKS are compartmentalized in the distal nephron. We have shown that kallikrein-like immunoreactivity and mRNA are first expressed in the distal end of the upper limb of S-shaped bodies (precursor of connecting tubule) [23, 41] . Vascularization of inner cortical glomeruli is temporally associated with an increased number of connecting tubular cells expressing tissue kallikrein, further emphasizing the relationship between kinins and nephron differentiation and acquisition of function [23, 41] . Preliminary studies also indicate that low molecular weight kininogen, the substrate for tissue kallikrein, is restricted to the terminal branches of the ureteric bud and forming collecting ducts in a pattern that overlaps with that of B2 receptors [42, 43] . Together, these data indicate that the developing distal ncphron expresses a paracrine! autocrine KKS.
The immunocytochemical studies in HOE-140-injcctcd newborn rats confirm the predominant localization of B2 receptors in the distal and collecting tubules. Furthermore, the results demonstrate that HOE-140, a selective B2 antagonist, is capable of reaching both proximal and distal sites within the developing nephron. This information is particularly important in light of the new data showing alterations of segmental nephron growth in HOE-140-trcatcd rat pups [27, 28] . The presence of HOE-140 imrnunoreactivity in the proximal tubular cells, despite lack of B2 receptors in this segment, can be explained by the finding that HOE-140 undergoes endocytosis in proximal tubular cells [321. In summary, the present study documents enhanced expression ..rt of bradykinin B2 receptors in the developing kidney. Expression of B2 receptors is restricted to the cells destined to give rise to the distal nephron, the site of kinin formation. The results suggest the hypothesis that kinins may play an important role as paracrine modulators of segmental nephron maturation.
